; and (C) submit such lists to the Congress; (2) not less than every 3 years thereafter, update the lists under paragraph (1) and submit the updated lists to the Congress; (3) consult with parties in Abraham Accords countries on good manufacturing practices and other issues relevant to manufacturing medical products that are regulated by the Food and Drug Administration; (4) facilitate interactions between the Food and Drug Administration and interested parties in Abraham Accords countries, including by sharing relevant information regarding United States regulatory pathways with such parties; (5) offer technical assistance on manufacturing drugs and devices to interested parties in Abraham Accords countries; and (6) carry out other functions and activities as the Secretary determines to be necessary to carry out this section. (d) Limitation Notwithstanding any other provision of this section, this section does not authorize any assistance to any entity in an Abrahams Accords country that, for purposes of manufacturing, uses any ingredient or product that is produced or manufactured in a covered country. (e) Definitions In this section: (1) The term Abraham Accords country means a country identified by the Department of State as having signed the Abraham Accords Declaration. (2) The term covered country means a country— (A) designated as a country of particular concern for religious freedom under section 402(b)(1)(A)(ii) of the International Religious Freedom Act of 1998; or (B) the government of which engages in a consistent pattern of gross violations of internationally recognized human rights, as defined in section 502B(d)(1) of the Foreign Assistance Act of 1961. (3) The term essential medical products shall have such definition as the Secretary may determine for purposes of this section. (4) The term primarily manufactured in a covered country means— (A) manufactured in a covered country in final form